inaya medical college (imc)image tracers by virtue of the gamma rays they emit. • this was...
TRANSCRIPT
DR. MOHAMMED MOSTAFA EMAM
INAYA MEDICAL COLLEGE
(IMC)RAD 243- LECTURE 2
Nuclear Medicine Treatments and Clinical Applications
Next Lectures Outlines
• Introduction to Nuclear Physics
• Physics of Radioactivity
• Radiation measurement Units
• Interaction of Radiation with Matter
• Radiation Detectors (Gas-filled and Scintillation
Detectors)
• Imaging Systems
• Applications of Nuclear Medicine Imaging in
Diagnosis and Therapy
Nuclear Medicine Treatments and Clinical Applications _ PART I2
References
• "Advancing Nuclear Medicine ThroughInnovation". Committee on State of the Scienceof Nuclear Medicine, National ResearchCouncil, USA. National Academies Press, 2007.
• K. Maher: "Basic Physics of Nuclear medicine".Wikibooks, 2006.
• W.D. Leslie, I.D. Greenberg: “NuclearMedicine”. Landes Bioscience, 2003.
• J. D. Bronzino: “The Biomedical EngineeringHandBook”. 2nd Edn., CRC Press, 2000.
• D.J. Dowsett, P.A. Kenny, R.E. Johnston: “ThePhysics of Diagnostic Imaging”. Chapman &Hall Medical, 1998.
Nuclear Medicine Treatments and Clinical Applications _ PART I3
Introduction
Nuclear Medicine Treatments and Clinical Applications _ PART I4
Definition
• Nuclear medicine is a highly multi-
disciplinary specialty that develops
and uses instrumentation and
radiopharmaceuticals to study
physiological processes and non-
invasively diagnose and treat
diseases.
Nuclear Medicine Treatments and Clinical Applications _ PART I5
Radiopharmaceuticals
A radiopharmaceutical is either;
• a radionuclide (also called radioisotope)
alone, such as iodine-131
• or a radionuclide that is attached to a
carrier molecule (a drug, protein, or
peptide)
• or particle, which when introduced into
the body by injection, swallowing, or
inhalation accumulates in the organ or
tissue of interest.Nuclear Medicine Treatments and Clinical Applications _ PART I
6
Radionuclides
• Radionuclides are chemical elements that
are radioactive.
Nuclear Medicine Treatments and Clinical Applications _ PART I7
Radionuclides
• Radionuclides are chemical elements that
are radioactive.
As we know,
• The nucleus of an unstable radionuclide becomes
stable by emitting particles, such as alpha or beta.
• The nucleus may also emit energy in the form of
electromagnetic radiation known as gamma rays.
Nuclear Medicine Treatments and Clinical Applications _ PART I8
Radionuclides
• Although radionuclides can be found in
nature, all radionuclides used in nuclear
medicine are produced in linear
accelerators, cyclotrons, or nuclear
reactors.
Nuclear Medicine Treatments and Clinical Applications _ PART I9
Radionuclides
• Although radionuclides can be found in
nature, all radionuclides used in nuclear
medicine are produced in linear
accelerators, cyclotrons, or nuclear
reactors.
• Each radionuclide has unique properties
that make it useful for certain diagnostic
and therapeutic tools.
Nuclear Medicine Treatments and Clinical Applications _ PART I10
EXTRACT
Commonly Used Radionuclides in ImagingImaging
Technique Used
Type of Emitted
Radiation
Half-LifeRadionuclide
PETPositron 20.33 minCarbon-11
PETPositron 9.97 minNitrogen-13
PETPositron 2.04 minOxygen-15
PETPositron 109.75 minFluorine-18
SPECTgamma6.02 hoursTechnetium-99m
SPECTgamma2.8 daysIndium-111
SPECTgamma13 hoursIodine-123
Nuclear Medicine Treatments and Clinical Applications _ PART I11
Commonly Used Radionuclides in Therapy
Type of Emitted
Radiation
Half-LifeRadionuclide
beta8 daysIodine-131
beta2.7 daysYttrium-90
Nuclear Medicine Treatments and Clinical Applications _ PART I12
Nuclear Medicine Scans
• In a nuclear medicine scan, a
radiopharmaceutical is administered to
the patient, and an imaging instrument
that detects radiation is used to show
biochemical changes in the body.
Nuclear Medicine Treatments and Clinical Applications _ PART I13EXTRACT
Nuclear Medicine Scans
• Nuclear medicine imaging, in contrast toimaging techniques that mainly show anatomy (e.g.,conventional ultrasound, computed tomography [CT],or magnetic resonance imaging [MRI])*, canprovide important quantitativefunctional information about normaltissues or disease conditions in livingsubjects.
* Exceptionally with the emergence of advanced(functional) MRI methods the pure anatomicalrole of these traditional imaging techniques isslowly reaching an end.
Nuclear Medicine Treatments and Clinical Applications _ PART I14
Nuclear Medicine Treatment
• For treatment, highly targeted
radiopharmaceuticals may be used to
deposit lethal radiation at tumor sites.
Nuclear Medicine Treatments and Clinical Applications _ PART I15
The Power of Nuclear Medicine
• The power of nuclear medicine in
clinical diagnosis rests with its ability
to detect altered function with great
sensitivity.
Nuclear Medicine Treatments and Clinical Applications _ PART I16
The Power of Nuclear Medicine
• The power of nuclear medicine in
clinical diagnosis rests with its ability
to detect altered function with great
sensitivity.
For this reason nuclear medicine hascontributed not only to clinical diagnosisbut, to an extent unmatched by otherimaging methods, to an understanding ofdisease mechanisms.
Nuclear Medicine Treatments and Clinical Applications _ PART I17
Research and Development (R&D)
Activities in the Nuclear Medicine Field
Toward improve disease diagnosis
• Development of new radionuclide production facilities and technologies, such as• nuclear reactors
• particle accelerators
• Development of chemical processes that synthesize new radiopharmaceuticals used • to improve understanding of how specific organs
function.
• for imaging and treatment
• Development of • imaging instruments
• enabling technologies
• multimodality imaging devices, such as PET/CT and PET/MRI
Nuclear Medicine Treatments and Clinical Applications _ PART I18
EXTRACT
Research and Development (R&D)
Activities in the Nuclear Medicine Field
Toward improve disease diagnosis
• Design and development of instruments which can
detect radiation emitted from the radionuclides that
accumulate in the human body.
• Development and use of targeted radionuclide
therapeutics that will allow cancer treatments to be
tailored for individual patients.
• Use of nuclear medicine imaging as a tool in the
discovery and development of new drugs.
Nuclear Medicine Treatments and Clinical Applications _ PART I19
EXTRACT
Current Clinical Applications of Nuclear Medicine
• Diagnosis of diseases to permit earlier initiation of treatment as well as reduced morbidity and mortality. Examples include:• cancer
• neurological disorders (e.g., Alzheimer’s and Parkinson’s diseases),
• cardiovascular disease in their initial stages
• Non-invasive assessment of therapeutic response, thus reducing patients’ exposure to the toxicity of ineffective treatments and allowing alternative treatments to be started earlier.
• Provision of molecularly targeted treatment of cancer and certain endocrine disorders (e.g., thyroid disease and neuro-endocrine tumors).
Nuclear Medicine Treatments and Clinical Applications _ PART I20
EXTRACT
Emerging Opportunities in Nuclear Medicine
• Understanding the relationship between
brain chemistry and behavior (e.g., addictive
behavior, eating disorders, depression).
• Assessment of the atherosclerotic
cardiovascular system.
• Understanding the metabolism and
pharmacology of new drugs.
Nuclear Medicine Treatments and Clinical Applications _ PART I21
EXTRACT
Emerging Opportunities in Nuclear Medicine
• Assessment of the efficacy of new drugs and other forms of treatments, thus speeding their introduction into clinical practice.
• Application of targeted radionuclide therapeutics to individualize treatment for cancer patients by tailoring the properties of the targeting vehicle and the radionuclide.
• Development of new technology platforms (e.g., integrated micro-fluidic chips and other automated screening technologies) that would accelerate and lower the cost of discovering and validating new molecular imaging probes, biomarkers, and radio-therapeutic agents.
Nuclear Medicine Treatments and Clinical Applications _ PART I22
EXTRACT
Emerging Opportunities in Nuclear Medicine
• Development of higher resolution, more sensitive imaging instruments to detect and quantify disease faster and more accurately.
• Further development and exploration of hybrid imaging instruments, such as positron emission tomography/magnetic resonance imaging (PET/MRI), to improve disease diagnosis and treatment.
• Improvement of radionuclide production, chemistry, and automation to lower the cost and increase the availability of radiopharmaceuticals by inventing a new miniaturized particle accelerator and associated technologies to produce short-lived radionuclidesfor local use in research and clinical programs.
Nuclear Medicine Treatments and Clinical Applications _ PART I23
EXTRACT
A Brief History
• Henri Becquerel discovered natural radioactivity in February 1896.
• The story was that he placed lumps of pitchblende on sealed photographic film in sunlight, with the intent of finding out if the rays of the sun induced any penetrating fluorescence in the mineral.
• By chance, on developing the film after a cloudy day he was surprised to find as much blackening of the photographic emulsion as had occurred in bright sunlight.
• He realized that the pitchblende itself was a source of the energetic rays.
Nuclear Medicine Treatments and Clinical Applications _ PART I24
A Brief History
• Later Mme. (Dr.) Marie and Dr. Pierre Curie
working in Paris described natural radioactivity
and discovered radium.
• Subsequently Mme. (Dr.) Irène Curie was to
observe the artificial induction of radioactivity.
• Rutherford, a British-educated, New Zealand
physicist working at McGill University in Montreal
went on to discover the structure of the atom.
• All won Nobel prizes—Becquerel and Curie jointly.
Next>Nuclear Medicine Treatments and Clinical Applications _ PART I
25
A stamp commemorating Becquerel’s discovery of radioactivity for which he received a Nobel Prize.
<BackNuclear Medicine Treatments and Clinical Applications _ PART I
26
A Brief History
• Another important insight came when a Hungarian scientist — George de Hevesy (a former student of Rutherford)—first used the tracer principle.
• He experimented with a plant having its roots in a water bath containing a radioactive isotope of lead.
• Hevesy was able to follow the rate of passage of the tracer through the stem of the plant with an instrument capable of detecting and measuring radioactivity.
• This use of radioactive atoms, present in minute amounts but acting as a marker of other, non-radioactive atoms came to be called the tracer principle.
• It only required that Hevesy’s insight be translated to people instead of plants, and for the tracer to be administered by injection instead of through a plant’s root system, for the power of nuclear medicine to become clear.
Next>
Nuclear Medicine Treatments and Clinical Applications _ PART I27
A stamp celebrating the anniversary of the Nobel Prize awarded to de Hevesy for the discovery of the tracer principle.
<BackNuclear Medicine Treatments and Clinical Applications _ PART I28
A Brief History
• Without a capacity to image the distribution of radiotracers in the body, the importance of nuclear medicine might be of little value.
• Dr. Benedict Cassen developed the first rectilinear scanner to image tracers by virtue of the gamma rays they emit.
• This was followed by the development of the gamma camera, able to image both static and changing distributions of radioactive tracers in the body, by Dr. Hal Anger.
• Then, Dr. David Kuhl and others went on to develop the concept of tomographic sectional imaging in nuclear medicine.
• Nuclear medicine, while beginning in the late nineteenth century, gained momentum through the twentieth.
• Medicine in the twenty-first century will continue to be fundamentally changed by the insights that nuclear medicine provides.
Nuclear Medicine Treatments and Clinical Applications _ PART I29
Comparative imaging and the Role of Nuclear Medicine
• Classical radiology had been rooted in
studies of structure.
• Another decisive advantage of nuclear
medicine is its capacity to be used in whole
body imaging.
Nuclear Medicine Treatments and Clinical Applications _ PART I30
Next Lecture
PART_II
Physics of Radioactivity
DR. MOHAMMED MOSTAFA EMAM
INAYA MEDICAL COLLEGE
(IMC)RAD 243- LECTURE 3
Nuclear Medicine Treatments and Clinical Applications (PART II)